Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
Analyses of Human Samples Collected in Clinical Trials
NCT00339664 · View on ClinicalTrials.gov ↗
Study Summary
Cancer patients in clinical trials donate various human samples (e.g., serum, plasma, blood, urine, feces, bile, saliva) for research purposes. The purpose of this study is to conduct further analyses on these existing samples from clinical trials that are being performed outside of, but in collaboration with, the National Cancer Institute.
Conditions Studied
Study Locations (17)
Maryland
- University of Maryland, Baltimore — Baltimore
- Johns Hopkins Medical Center — Baltimore
- Sidney Kimmel Comprehensive Cancer Center — Baltimore
- National Institutes of Health Clinical Center, 9000 Rockville Pike — Bethesda
Pennsylvania
- University of Maryland at Amish Research Clinic, Lancaster — Lancaster
- Abramson Cancer Center, University of Pennsylvania — Philadelphia
- Hillman Cancer Center at University of Pittsburg Cancer Institute — Pittsburgh
Virginia
- McGuire Veterans Administration Medical Center — Richmond
- Massey Cancer Center, Virginia Commonwealth University — Richmond
Other
- Leiden University Medical Center — Leiden
- Erasmus Medical Center — Rotterdam
District of Columbia
- Childrens National Medical Center — Washington D.C.
Florida
- H. Lee Moffitt Cancer Center & Research Institute — Tampa
Illinois
- University of Chicago — Chicago
Minnesota
- Mayo Clinic, Rochester — Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,579 participants |
| Start Date | 2003-07-02 |
| Est. Completion | 2020-03-26 |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00339664
The ClinicalTrials.gov registry entry for NCT00339664 describes a study currently listed as completed. It is categorized as an unspecified phase, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 2,579 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Cancer Institute (NCI), which has 2,390 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 4 conditions, with Prostate Cancer appearing as the primary indexed condition, and to 0 interventions. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT00339664 reports 17 study locations spanning 10 distinct geographic areas — top geographies include Maryland, Pennsylvania, Virginia. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT00339664 about?
NCT00339664 is a clinical study titled "Analyses of Human Samples Collected in Clinical Trials". Cancer patients in clinical trials donate various human samples (e.g., serum, plasma, blood, urine, feces, bile, saliva) for research purposes. The purpose of this study is to conduct further analyses on these existing samples from clinical trials that are being performed outside of, but in collabo...
What is the current status of trial NCT00339664?
This trial is currently completed. The enrollment target is 2,579 participants. The study started on 2003-07-02. Estimated completion is 2020-03-26.
What conditions does trial NCT00339664 study?
This clinical trial studies the following conditions: Prostate Cancer, Neoplasm Metastasis, Leukemia, Myeloid, Leukemia, Lymphoid. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
Who is sponsoring clinical trial NCT00339664?
This trial is sponsored by National Cancer Institute (NCI), which has 2,390 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT00339664 being conducted?
This trial has 17 study locations across District of Columbia, Florida, Illinois, Maryland, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.